PDF《翰森制药集团有限公司》

This Application Form uses the same terms as defined in the prospectus of Hansoh Pharmaceutical Group Company Limited (the Company ) dated Friday, May 31,

2019 (the Prospectus ).

本申请表格使用翰森制药集团有限公司 ( 「本公司」 ) 於2019年5月31日 (星期五) 刊发的招股章程 ( 「招股章程」 ) 所界定的相同词汇. Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the United States without registration or an exemption from registration under the U.S. Securities Act. 本申请表格及招股章程概不构成在香港以外的任何司法区要约出售或游说要约购买任何香港发售股份.若无根拦と 法登记或获豁免登记,香港发售股份不得在美国提呈发售或出售. This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction. 任何根钡胤坏梅⑺汀⑴煞⒒蚋粗票旧昵氡砀窦罢泄烧鲁痰乃痉ㄝ区内概不得发送或派发或复制 (不论以任何方式,亦 不论全部或部分) 本申请表格及招股章程. Copies of the Prospectus, all related Application Forms and the other documents specified in Appendix V ― Documents Delivered to the Registrar of Companies and Available for Inspection to the Prospectus have been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter

32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the Stock Exchange ), Hong Kong Securities Clearing Company Limited ( HKSCC ), the Securities and Futures Commission of Hong Kong (the SFC ) and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents. 招股章程、所有相关申请表格及招股章程 「附录五-送呈公司注册处处长及备查文件」 所述的其他文件已遵照香港法例第

32 章 《公司 (清盘及杂项条文) 条例》 第342C 条的规定送呈香港公司注册处处长登记.香港交易及结算所有限公司、香港联合交易所 有限公司 ( 「联交所」 ) 、香港中央结算有限公司 ( 「香港结算」 ) 、香港证券及期货事务监察委员会 ( 「证监会」 ) 及香港公司注册处 处长对此等文件的内容概不负责. Hansoh Pharmaceutical Group Company Limited 翰森制药集团有限公司(Incorporated in the Cayman Islands with limited liability) (於开曼群岛注册成立的有限公司) Stock Code :

3692 股份代号 :

3692 Maximum Offer Price : HK$14.26 per Offer Share plus brokerage of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) 最高发售价 : 每股发售股份 14.26港元,另加 1% 经纪佣金、 0.0027% 证监会交易徵费及 0.005% 联交所交 易费 (须在申请时以港元缴足,多缴股款可予退 还) You should read this Application Form in conjunction with the Prospectus, which contains further information on the application procedures. 招股章程载有关於申请手续的进一步资料,本申请表格应与招股章程一并阅读. Application Form 申请表格 Staple your payment here 请将股款 紧钉在此 To: Hansoh Pharmaceutical Group Company Limited The Joint Global Coordinators The Joint Sponsors The Joint Bookrunners The Hong Kong Underwriters Applicants'